Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor Lymphoma

Clinical trial NCT06652152 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06652152
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Diffuse Large B Cell Lymphoma (DLBCL)Double Expressor Lymphoma

Start date: 2024-10-30
Primary completion: 2025-05-30
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.